Posted by Michael Wonder on 12 Dec 2017
Decision to widen access to various anti-infectives
12 December 2017 - PHARMAC is pleased to announce our decision to widen funded access to three treatments:
- Ledipasvir with sofosbuvir
- Tenofovir disoproxil fumarate
- Paromomycin
All changes will take effect from 1 January 2018.
